ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J01MA14 | G | Moxifloxacin (HCl) - 400mg/250ml | 9656 | 72716/1 | MOFLOXINE | 400mg/250ml | 1x250ml | Injectable solution | Infusion | Bellapharma S.A.R.L. | MS Pharma | Jordan | 1,153,107 L.L | 23.08 | B | MS Pharma | Jordan | 2/1/2023 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J01MA14 | B | Moxifloxacin (HCl) - 400mg/250ml | 5222 | 208571/03 | AVALOX | 400mg/250ml | 5 x 250ml | Injectable solution | Infusion | Droguerie R. Pharaon & Fils S.A.L. | Fresenius Kabi Italia SRL, Italy | Italy | 6,372,457 L.L | 21.26 | C | Bayer AG | Germany | 2/1/2023 |
J01MA14 | G | Moxifloxacin (HCl) - 400mg/250ml | 10222 | 140716/1 | MIKROBIEL | 400mg/250ml | 250ml | Injectable solution | Infusion | PharmaLab SARL | Cooper SA | Greece | 1,150,269 L.L | 23.08 | B | Cooper SA | Greece | 2/1/2023 |